Latest Breaking News On - Molecular oncology research unit - Page 2 : comparemela.com

Fear that delayed second COVID-19 vaccine dose could lead to new variants realistic by Jacob Serebrin, The Canadian Press Posted Feb 3, 2021 5:08 pm EDT Last Updated Feb 3, 2021 at 5:14 pm EDT MONTREAL Experts say delaying the second dose of some COVID-19 vaccines could lead to the emergence of new variants of the virus but there’s no sign it has happened yet. “It’s a theoretical, realistic possibility, but there is no evidence so far,” said Dr. Andre Veillette, a professor at the Universite de Montreal and the director of the Molecular Oncology Research Unit at the Montreal Clinical Research Institute.  Veillette, who is a member of the federal government’s COVID-19 vaccine task force, said there’s a concern that the immunity provided by one dose of the Pfizer-BioNTech and Moderna vaccines “is not as strong as you would get with two doses.”

United statesHoracio arrudaJacob serebrinAndre veilletteCaroline quachJorg fritzMontreal clinical research instituteCanadian press news fellowshipNational advisory committee on immunizationMolecular oncology research unitMcgill universityUniversite de montrealMontreal clinical researchNational advisory committeeCanadian pressCanadian press news